Literature DB >> 33023446

New Heterocyclic Compounds: Synthesis, Antioxidant Activity and Computational Insights of Nano-Antioxidant as Ascorbate Peroxidase Inhibitor by Various Cyclodextrins as Drug Delivery Systems.

Yassine Kaddouri1, Farid Abrigach1, El Bekaye Yousfi2, Belkheir Hammouti1, Mohamed El Kodadi1, Ali Alsalme3, Nabil Al-Zaqri3, Ismail Warad4, Rachid Touzani1.   

Abstract

AIM: The synthesis of seven new antioxidant agents based on the combination of thiazole, pyridine, triazole and pyrazole moieties. The studies of their antioxidant activity using DPPH reduction method. The DFT analysis of the 7 ligands. The docking study was also investigated. The better binding affinity with α-cyclodextrin as best drug delivery system.
BACKGROUND: The screening of new antioxidant compounds and find the good mechanism for binding sites, with correlating between experience and computer theory.
OBJECTIVES: The DFT analysis of the 7 synthesized ligands.The docking study was also investigated by using the amino acids Ala167 and Arg172. The better binding affinity with α-cyclodextrin as best drug delivery system.
METHODS: The studies of their antioxidant activity using DPPH reduction method.
RESULTS: Chemistry: synthesis of 7 ligands by condensation reaction with 89% yield. Antioxidant activities using DPPH reduction with a good value IC50=13.05 ± 3.73 μg/ml. Using DFT (EHOMO and ELUMO) and Docking APX with the amino acids Ala167 and Arg172 compared to the ascorbic acid. Correlation between all these properties. α-cyclodextrin as best drug delivery system (better binding affinity than caffeic acid).
CONCLUSION: For the drug delivery study, The ACD is best system for all the compounds due to the smallest cavity size which makes the binding affinities favorable and possible to prepare prospective nano-antioxidants. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  DFT; DPPH; Pyrazole; cyclodextrin; docking; drug delivery system; triazole

Year:  2021        PMID: 33023446     DOI: 10.2174/1567201817999201001205627

Source DB:  PubMed          Journal:  Curr Drug Deliv        ISSN: 1567-2018            Impact factor:   2.565


  1 in total

1.  Pyrazole, imidazole and triazole: In silico, docking and ADMET studies against SARS-CoV-2.

Authors:  Mounir Mohamed; Farid Abrigach; Sghir El Kadiri; Said Omar Said Hassane; Magda H Abdellattif; Rachid Touzani
Journal:  Mater Today Proc       Date:  2022-09-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.